|
|
||||||||



* Max Delbrück Center for Molecular Medicine, Berlin, Germany; and
Institute of Reconstructive Neurobiology, Stem Cell Engineering Group, University of Bonn-Life and Brain Center and Hertie Foundation, Bonn, Germany
1Correspondence: Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, Berlin 13125, Germany. E-mail: cardoso{at}mdc-berlin.de
Cell-penetrating peptides (CPPs) are capable of introducing a wide range of cargoes into living cells. Descriptions of the internalization process vary from energy-independent cell penetration of membranes to endocytic uptake. To elucidate whether the mechanism of entry of CPP constructs might be influenced by the properties of the cargo, we used time lapse confocal microscopy analysis of living mammalian cells to directly compare the uptake of the well-studied CPP TAT fused to a protein (>50 amino acids) or peptide (<50 amino acids) cargo. We also analyzed various constructs for their subcellular distribution and mobility after the internalization event. TAT fusion proteins were taken up largely into cytoplasmic vesicles whereas peptides fused to TAT entered the cell in a rapid manner that was dependent on membrane potential. Despite their accumulation in the nucleolus, photobleaching of TAT fusion peptides revealed their mobility. The bioavailability of internalized TAT peptides was tested and confirmed by the strong inhibitory effect on cell cycle progression of two TAT fusion peptides derived from the tumor suppressor p21WAF/Cip and DNA Ligase I measured in living cells.Tünnemann, G., Martin, R. M., Haupt, S., Patsch, C., Edenhofer, F., Cardoso, M. C. Cargo-dependent mode of uptake and bioavailability of TAT-containing proteins and peptides in living cells.
Key Words: cell-penetrating peptide protein transduction PCNA PBD Cre recombinase
This article has been cited by other articles:
![]() |
R. Juliano, Md. R. Alam, V. Dixit, and H. Kang Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides Nucleic Acids Res., July 1, 2008; 36(12): 4158 - 4171. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Lavigne, L. Yates, P. Coxhead, and D. C. Gorecki Nuclear-targeted chimeric vector enhancing nonviral gene transfer into skeletal muscle of Fabry mice in vivo FASEB J, June 1, 2008; 22(6): 2097 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Tacken, B. Joosten, A. Reddy, D. Wu, A. Eek, P. Laverman, A. Kretz-Rommel, G. J. Adema, R. Torensma, and C. G. Figdor No Advantage of Cell-Penetrating Peptides over Receptor-Specific Antibodies in Targeting Antigen to Human Dendritic Cells for Cross-Presentation J. Immunol., June 1, 2008; 180(11): 7687 - 7696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Lopez, S. A. Belmonte, G. A. De Blas, and L. S. Mayorga Membrane-permeant Rab3A triggers acrosomal exocytosis in living human sperm FASEB J, December 1, 2007; 21(14): 4121 - 4130. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, N. Pischon, A. H. Palamakumbura, and P. C. Trackman Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2095 - C2102. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |